Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Return on Equity: 2019-2025

Historic Return on Equity for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to -0.28%.

  • Eton Pharmaceuticals' Return on Equity rose 9.00% to -0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.28%, marking a year-over-year increase of 9.00%. This contributed to the annual value of -0.19% for FY2024, which is 13.00% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Return on Equity of -0.28% as of Q3 2025, which was down 66.42% from -0.17% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Return on Equity registered a high of 0.13% during Q3 2023, and its lowest value of -0.90% during Q2 2022.
  • Moreover, its 3-year median value for Return on Equity was -0.19% (2025), whereas its average is -0.19%.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Return on Equity soared by 487bps in 2021, and later plummeted by 63bps in 2022.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Equity (Quarterly) stood at -0.12% in 2021, then tumbled by 63bps to -0.74% in 2022, then skyrocketed by 69bps to -0.06% in 2023, then fell by 13bps to -0.19% in 2024, then rose by 9bps to -0.28% in 2025.
  • Its Return on Equity stands at -0.28% for Q3 2025, versus -0.17% for Q2 2025 and -0.19% for Q1 2025.